Penn Medicine Provider
Medical Oncology
Lawrence N. Shulman, MD
5.0
(47)
Accepting new patients
Sees patients age 18 and up
Abramson Cancer Center Perelman 3rd Floor West

About me

  • Director, Center for Global Cancer Medicine, Abramson Cancer Center
  • Clinical Associate of Medicine
  • Professor of Medicine (Hematology-Oncology) at the Hospital of the University of Pennsylvania

Education and training

  • Medical School: Harvard Medical School
  • Residency: Beth Israel Deaconess Medical Center
  • Fellowship: Beth Israel Deaconess Medical Center

What my patients think about me

Average Rating
5.0

47 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

January 2025
5.0
5.0
very efficient, polite and so very attentive.
January 2025
5.0
5.0
i appreciate both his level of expertise and kindness.
December 2024
5.0
5.0
just feel he is thorough and caring.
November 2024
5.0
5.0
great health care.

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
Dr. Shulman is a Penn Medicine physician.

Qualifications and experience

My research

Jacobs L, Shulman L Cardio-Oncology Care Delivery for All Patients With Cancer Within Academic and Community Settings. , J Am Coll Cardiol CardioOnc. 2024, 0 (0) doi: 10.1016/j.jaccao.2023.10.010: 2024


Unger JM, Shulman LN, Facktor MA, Nelson H, Fleury ME National Estimates of the Participation of Patients With Cancer in Clinical Research Studies Based on Commission on Cancer Accreditation Data. , J Clin Oncol. 2024 Apr 2:JCO2301030. doi: 10.1200/JCO.23.01030. Epub ahead of print. PMID: 38564681: 2024


Martei YM, Mokokwe L, Ngwako N, Kebuang K, Setlhako DI, Gabaatlhole G, Baaitse B, Segadimo T, Shulman LN, Barg F, Gaolebale BE. Development, acceptability and usability of culturally appropriate survivor narrative videos for breast cancer treatment in Botswana: a pilot study , BMJ Open. 2024 Jan 30;14(1):e073867. doi: 10.1136/bmjopen-2023-073867. PMID: 38296302; PMCID: PMC10828869: 2024


Manz CR, Schriver E, Ferrell WJ, Williamson J, Wakim J, Khan N, Kopinsky M, Balachandran M, Chen J, Patel MS, Takvorian SU, Shulman LN, Bekelman JE, Barnett IJ, Parikh RB Association of Remote Patient-Reported Outcomes and Step Counts With Hospitalization or Death Among Patients With Advanced Cancer Undergoing Chemotherapy: Secondary Analysis of the PROStep Randomized Trial. , J Med Internet Res. 2024 May 17;26:e51059. doi: 10.2196/51059.PMID: 38758583 : 2024


Bourlon MT, Bhatt AS, Lopes G, Asirwa FC, Eniu AE, Loehrer PJ, Shulman LN, Close J, Von Roenn J, Tibbits M, Pyle D, Gralow JR Envisioning Academic Global Oncologists: Proposed Competencies for Global Oncology Training From ASCO , JCO Glob Oncol. 2024 Apr;10:e2300157. doi: 10.1200/GO.23.00157. PMID: 38603655: 2024


Lau-Min KS, Marini J, Shah NK, Pucci D, Blauch AN, Cambareri C, Mooney B, Agarwal P, Johnston C, Schumacher RP, White K, Gabriel PE, Rosin R, Jacobs LA, Shulman LN. Pilot Study of a Mobile Phone Chatbot for Medication Adherence and Toxicity Management Among Patients With GI Cancers on Capecitabine , JCO Oncol Pract. 2024 Jan 18:OP2300365. doi: 10.1200/OP.23.00365. Epub ahead of print. PMID: 38237102: 2024


Boffa DJ, Nelson H, Mullett T, Opelka F, Turner PL, Shulman LN. Privacy on the Road to Personalized Medicine , J Natl Compr Canc Netw. 2024 Jan 4:1-5. doi: 10.6004/jnccn.2023.7101. Epub ahead of print. PMID: 38176100.: 2024


Takvorian SU, Gabriel P, Wileyto EP, Blumenthal D, Tejada S, Clifton ABW, Asch DA, Buttenheim AM, Rendle KA, Shelton RC, Chaiyachati KH, Fayanju OM, Ware S, Schuchter LM, Kumar P, Salam T, Lieberman A, Ragusano D, Bauer AM, Scott CA, Shulman LN, Schnoll R, Beidas RS, Bekelman JE, Parikh RB. Clinician- and Patient-Directed Communication Strategies for Patients With Cancer at High Mortality Risk: A Cluster Randomized Trial. , JAMA Netw Open. 2024 Jul 1;7(7):e2418639. doi: 10.1001/jamanetworkopen.2024.18639.PMID: 38949813 : 2024


Marmarelis ME, Scholes DG, McWilliams TL, Hwang WT, Kosteva J, Costello MR, Sun L, Singh AP, Lau-Min KS, Doucette A, Gabriel PE, Martella AO, Roy MA, Thompson JC, Cohen RB, Dougherty DW, Shulman LN, Langer CJ, Bekelman JE, Carpenter EL, Aggarwal C. Electronic Medical Record-Based Nudge Intervention to Increase Comprehensive Molecular Genotyping in Patients With Metastatic Non-Small Cell Lung Cancer: Results From a Prospective Clinical Trial. , JCO Oncol Pract. 2024 Jul 3:OP2400070. doi: 10.1200/OP.24.00070. Online ahead of print.PMID: 38959441: 2024


DeBoer RJ, Ho A, Mutoniwase E, Nguyen C, Umutesi G, Bigirimana JB, Nsabimana N, Van Loon K, Shulman LN, Triedman SA, Cubaka VK, Shyiramere C. Ethical dilemmas in prioritizing patients for scarce radiotherapy resources , BMC Med Ethics. 2024 Jan 31;25(12). doi: 10.1186/s12910-024-01005-3: 2024